SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/29/20 Jrsis Health Care Corp 10-Q 3/31/20 78:3.6M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 273K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 22K 12: R1 Document and Entity Information HTML 54K 13: R2 Consolidated Balance Sheets HTML 127K 14: R3 Consolidated Balance Sheets (Parenthetical) HTML 30K 15: R4 Consolidated Statements of Operations and HTML 125K Comprehensive Income (Unaudited) 16: R5 Consolidated Statement of Sharesholders' Equity HTML 45K (Unaudited) 17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 104K 18: R7 Description of Business and Organization HTML 28K 19: R8 Summaries of Significant Accounting Policies HTML 90K 20: R9 Accounts Receivable, Net HTML 27K 21: R10 Inventories HTML 27K 22: R11 Prepayment HTML 26K 23: R12 Property and Equipment HTML 31K 24: R13 Long Term Deferred Expenses HTML 25K 25: R14 Right-of-Use Assets and Lease Liabilities HTML 58K 26: R15 Derivative Financial Instruments HTML 29K 27: R16 Non-controlling Interests HTML 25K 28: R17 Revenue HTML 34K 29: R18 Income Tax Expense HTML 27K 30: R19 Related Party Transactions HTML 38K 31: R20 Basic and Diluted Earnings Per Share HTML 31K 32: R21 Contingencies and Commitment HTML 26K 33: R22 Common Stock HTML 23K 34: R23 Going Concern HTML 26K 35: R24 Subsequent Events HTML 24K 36: R25 Summaries of Significant Accounting Policies HTML 141K (Policies) 37: R26 Summaries of Significant Accounting Policies HTML 53K (Tables) 38: R27 Accounts Receivable, Net (Tables) HTML 26K 39: R28 Inventories (Tables) HTML 28K 40: R29 Prepayment (Tables) HTML 25K 41: R30 Property and Equipment (Tables) HTML 29K 42: R31 Right-of-Use Assets and Lease Liabilities (Tables) HTML 48K 43: R32 Revenue (Tables) HTML 33K 44: R33 Related Party Transactions (Tables) HTML 34K 45: R34 Basic and Diluted Earnings Per Share (Tables) HTML 31K 46: R35 Description of Business and Organization (Details) HTML 40K 47: R36 Summaries of Significant Accounting Policies HTML 31K (Details) 48: R37 Summaries of Significant Accounting Policies HTML 43K (Details 1) 49: R38 Summaries of Significant Accounting Policies HTML 32K (Details 2) 50: R39 Summaries of Significant Accounting Policies HTML 28K (Details 3) 51: R40 Summaries of Significant Accounting Policies HTML 41K (Details 4) 52: R41 Summaries of Significant Accounting Policies HTML 27K (Details 5) 53: R42 Summaries of Significant Accounting Policies HTML 38K (Details Textual) 54: R43 Accounts Receivable, Net (Details) HTML 30K 55: R44 Accounts Receivable, Net (Details Textual) HTML 24K 56: R45 Inventories (Details) HTML 32K 57: R46 Prepayment (Details) HTML 30K 58: R47 Property and Equipment (Details) HTML 45K 59: R48 Property and Equipment (Details Textual) HTML 23K 60: R49 Long Term Deferred Expenses (Details) HTML 33K 61: R50 Right-of-Use Assets and Lease Liabilities HTML 41K (Details) 62: R51 Right-of-Use Assets and Lease Liabilities (Details HTML 32K 1) 63: R52 Right-of-Use Assets and Lease Liabilities (Details HTML 32K 2) 64: R53 Right-of-Use Assets and Lease Liabilities (Details HTML 32K 3) 65: R54 Right-of-Use Assets and Lease Liabilities (Details HTML 68K Textual) 66: R55 Derivative Financial Instruments (Details) HTML 40K 67: R56 Non-controlling Interests (Details) HTML 36K 68: R57 Revenue (Details) HTML 41K 69: R58 Income Tax Expense (Details) HTML 35K 70: R59 Related Party Transactions (Details) HTML 33K 71: R60 Related Party Transactions (Details 1) HTML 28K 72: R61 Related Party Transactions (Details Textual) HTML 31K 73: R62 Basic and Diluted Earnings Per Share (Details) HTML 43K 74: R63 Common Stock (Details) HTML 29K 75: R64 Going Concern (Details) HTML 25K 77: XML IDEA XML File -- Filing Summary XML 140K 76: EXCEL IDEA Workbook of Financial Reports XLSX 87K 6: EX-101.INS XBRL Instance -- jrss-20200331 XML 972K 8: EX-101.CAL XBRL Calculations -- jrss-20200331_cal XML 182K 9: EX-101.DEF XBRL Definitions -- jrss-20200331_def XML 475K 10: EX-101.LAB XBRL Labels -- jrss-20200331_lab XML 927K 11: EX-101.PRE XBRL Presentations -- jrss-20200331_pre XML 680K 7: EX-101.SCH XBRL Schema -- jrss-20200331 XSD 181K 78: ZIP XBRL Zipped Folder -- 0001213900-20-016048-xbrl Zip 117K
EXHIBIT 31.1
Certification of Principal Executive Officer
Section 302 Certification
I, Lihua Sun, certify that:
1. I have reviewed this quarterly report on Form 10-Q for JRSIS HEALTH CARE CORPORATION.
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and the internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: | June 29, 2020 | /s/ Lihua Sun |
Lihua Sun, Chief Executive Officer | ||
(Principal Executive Officer) |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/29/20 | None on these Dates | ||
For Period end: | 3/31/20 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/21/20 Jrsis Health Care Corp. POS AM 2:324K EdgarAgents LLC/FA |